BBA
Baker Bros. Advisors Portfolio holdings
AUM
$10.3B
This Quarter Return
+2.67%
1 Year Return
+63.34%
3 Year Return
+231.6%
5 Year Return
+293.68%
10 Year Return
+1,612.7%
AUM
$8.16B
AUM Growth
+$8.16B
(+3.8%)
Cap. Flow
+$212M
Cap. Flow
% of AUM
2.6%
Top 10 Holdings %
Top 10 Hldgs %
74.41%
Holding
115
New
7
Increased
22
Reduced
9
Closed
9
Top Buys
| 1 |
PCYC
PHARMACYCLICS INC
PCYC
|
$76.6M |
| 2 |
AVNR
AVANIR PHARMACEUTICALS, INC CL A
AVNR
|
$72M |
| 3 |
SGEN
Seagen Inc. Common Stock
SGEN
|
$66.3M |
| 4 |
BioCryst Pharmaceuticals
BCRX
|
$64.1M |
| 5 |
ARAV
Aravive, Inc. Common Stock
ARAV
|
$34.9M |
Top Sells
| 1 |
ICPT
Intercept Pharmaceuticals, Inc.
ICPT
|
$84.6M |
| 2 |
CHTP
CHELSEA THERAPEUTICS INT'L LTD
CHTP
|
$37.3M |
| 3 |
Halozyme
HALO
|
$28.9M |
| 4 |
Gilead Sciences
GILD
|
$24.9M |
| 5 |
QCOR
QUESTCOR PHARMA INC
QCOR
|
$20.1M |
Sector Composition
| 1 | Healthcare | 39.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
GEVA
1
DELISTED
SYNAGEVA BIOPHARMA CORP COM STK (DE)
GEVA
| $1.12B | 13.68% | 10,660,432 +12,250 | +0.1% | +$1.28M |
|
|
PCYC
2
DELISTED
PHARMACYCLICS INC
PCYC
| $860M | 10.54% | 9,591,546 +853,658 | +10% | +$76.6M |
|
|
SGEN
3
DELISTED
Seagen Inc. Common Stock
SGEN
| $860M | 10.53% | 22,472,229 +1,732,803 | +8% | +$66.3M |
|
4
Incyte
INCY
$16.5B
| $838M | 10.26% | 14,845,559 +10,000 | +0.1% | +$564K |
|
5
Acadia Pharmaceuticals
ACAD
$4.38B
| $463M | 5.67% | 20,481,442 | – | – |
|
|
GHDX
6
DELISTED
Genomic Health, Inc.
GHDX
| $374M | 4.58% | 13,654,902 +752 | +0% | +$20.6K |
|
|
ITMN
7
DELISTED
INTERMUNE INC
ITMN
| $209M | 2.55% | 4,722,869 +398,026 | +9% | +$17.6M |
|
|
8
BioCryst Pharmaceuticals
BCRX
$1.74B
| $139M | 1.7% | 10,890,872 +5,023,841 | +86% | +$64.1M |
|
9
BioMarin Pharmaceuticals
BMRN
$11.2B
| $119M | 1.45% | 1,908,230 +25,000 | +1% | +$1.56M |
|
10
Xoma
XOMA
$392M
| $106M | 1.3% | 23,065,972 +8,400 | +0% | +$38.6K |
|
|
AVNR
11
DELISTED
AVANIR PHARMACEUTICALS, INC CL A
AVNR
| $105M | 1.28% | 18,558,487 +12,768,348 | +221% | +$72M |
|
12
Vanda Pharmaceuticals
VNDA
$279M
| $70.7M | 0.87% | 4,372,153 -73,543 | -2% | -$1.19M |
|
|
ANAC
13
DELISTED
ANACOR PHARMACEUTICALS INC COM
ANAC
| $57.6M | 0.71% | 3,248,043 +152,725 | +5% | +$2.71M |
|
|
DYAX
14
DELISTED
DYAX CORPORATION
DYAX
| $54.5M | 0.67% | 5,681,237 +3,149,471 | +124% | +$30.2M |
|
|
RPRX
15
DELISTED
Repros Therapeutics Inc.
RPRX
| $48.1M | 0.59% | 2,778,654 | – | – |
|
|
MRTX
16
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $47.6M | 0.58% | 2,380,074 | – | – |
|
|
QCOR
17
DELISTED
QUESTCOR PHARMA INC
QCOR
| $46.2M | 0.57% | 500,000 -217,745 | -30% | -$20.1M |
|
18
Cerus
CERS
$251M
| $42.5M | 0.52% | 10,246,591 +1,791,285 | +21% | +$7.43M |
|
|
DSCI
19
DELISTED
Derma Sciences, Inc. Common Stock (DE)
DSCI
| $40.9M | 0.5% | 3,537,137 | – | – |
|
|
ARAV
20
DELISTED
Aravive, Inc. Common Stock
ARAV
| $34.9M | 0.43% | +1,245,889 | New | +$34.9M |
|
|
CLVS
21
DELISTED
Clovis Oncology, Inc.
CLVS
| $32.8M | 0.4% | 793,221 +263,231 | +50% | +$10.9M |
|
22
Heron Therapeutics
HRTX
$207M
| $32.1M | 0.39% | 2,607,784 +440,000 | +20% | +$5.42M |
|
|
ACOR
23
DELISTED
Acorda Therapeutics, Inc.
ACOR
| $30.5M | 0.37% | 906,091 -93,909 | -9% | -$3.17M |
|
|
24
Halozyme
HALO
$8.56B
| $27.4M | 0.34% | 2,776,143 -2,921,996 | -51% | -$28.9M |
|
|
25
Gilead Sciences
GILD
$140B
| $21.2M | 0.26% | 256,108 -300,000 | -54% | -$24.9M |
|